» Articles » PMID: 18302806

Predicting Mortality with Pneumonia Severity Scores: Importance of Model Recalibration to Local Settings

Overview
Date 2008 Feb 28
PMID 18302806
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

In patients with community-acquired pneumonia (CAP) prediction rules based on individual predicted mortalities are frequently used to support decision-making for in-patient vs. outpatient management. We studied the accuracy and the need for recalibration of three risk prediction scores in a tertiary-care University hospital emergency-department setting in Switzerland. We pooled data from patients with CAP enrolled in two randomized controlled trials. We compared expected mortality from the original pneumonia severity index (PSI), CURB65 and CRB65 scores against observed mortality (calibration) and recalibrated the scores by fitting the intercept alpha and the calibration slope beta from our calibration model. Each of the original models underestimated the observed 30-day mortality of 11%, in 371 patients admitted to the emergency department with CAP (8.4%, 5.5% and 5.0% for the PSI, CURB65 and CRB65 scores, respectively). In particular, we observed a relevant mortality within the low risk classes of the original models (2.6%, 5.3%, and 3.7% for PSI classes I-III, CURB65 classes 0-1, and CRB65 class 0, respectively). Recalibration of the original risk models corrected the miscalibration. After recalibration, however, only PSI class I was sensitive enough to identify patients with a low risk (i.e. <1%) for mortality suitable for outpatient management. In our tertiary-care setting with mostly referred in-patients, CAP risk scores substantially underestimated observed mortalities misclassifying patients with relevant risks of death suitable for outpatient management. Prior to the implementation of CAP risk scores in the clinical setting, the need for recalibration and the accuracy of low-risk re-classification should be studied in order to adhere with discharge guidelines and guarantee patients' safety.

Citing Articles

Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young.

Cardoso P, McDonald T, Patel K, Pearson E, Hattersley A, Shields B BMC Med Res Methodol. 2024; 24(1):128.

PMID: 38834992 PMC: 11149229. DOI: 10.1186/s12874-024-02239-w.


Assessment of a novel BLOOMY score for predicting mortality in hospitalised adults with bloodstream infection.

Tietavainen J, Seiskari T, Aittoniemi J, Huhtala H, Mustonen J, Huttunen R Infection. 2024; 52(4):1511-1517.

PMID: 38652226 PMC: 11289069. DOI: 10.1007/s15010-024-02254-5.


Risk Prediction Models for Hospital Mortality in General Medical Patients: A Systematic Review.

Hydoub Y, Walker A, Kirchoff R, Alzubi H, Chipi P, Gerberi D Am J Med Open. 2023; 10.

PMID: 38090393 PMC: 10715621. DOI: 10.1016/j.ajmo.2023.100044.


Updating cut-off values of severity scoring systems for community-acquired pneumonia to orchestrate more predictive accuracy.

Guo Q, Li H, Song W, Li M, Chen X, Liu H Ann Med. 2023; 55(1):2202414.

PMID: 37074414 PMC: 10120525. DOI: 10.1080/07853890.2023.2202414.


A literature review of severity scores for adults with influenza or community-acquired pneumonia - implications for influenza vaccines and therapeutics.

Adams K, Tenforde M, Chodisetty S, Lee B, Chow E, Self W Hum Vaccin Immunother. 2021; 17(12):5460-5474.

PMID: 34757894 PMC: 8903905. DOI: 10.1080/21645515.2021.1990649.


References
1.
Flanders W, Tucker G, Krishnadasan A, Martin D, HONIG E, McClellan W . Validation of the pneumonia severity index. Importance of study-specific recalibration. J Gen Intern Med. 1999; 14(6):333-40. PMC: 1496595. DOI: 10.1046/j.1525-1497.1999.00351.x. View

2.
Fine M, Auble T, Yealy D, Hanusa B, Weissfeld L, Singer D . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336(4):243-50. DOI: 10.1056/NEJM199701233360402. View

3.
Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay M, Huber P, Tamm M . Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004; 363(9409):600-7. DOI: 10.1016/S0140-6736(04)15591-8. View

4.
Niederman M, Mandell L, Anzueto A, Bass J, Broughton W, Campbell G . Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001; 163(7):1730-54. DOI: 10.1164/ajrccm.163.7.at1010. View

5.
Buising K, Thursky K, Black J, MacGregor L, Street A, Kennedy M . A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax. 2006; 61(5):419-24. PMC: 2111174. DOI: 10.1136/thx.2005.051326. View